Melanoma-Targeted Chemothermotherapy and In Situ Peptide Immunotherapy through HSP Production by Using Melanogenesis Substrate, NPrCAP, and Magnetite Nanoparticles

Figure 2

Strategy for melanogenesis-targeted CTI and in situ peptide vaccine therapy by conjugates of NPrCAP and magnetite nanoparticles with AMF exposure.